Abstract. We have examined the role of the glutathione redox cycle as an antioxidant defense mechanism in cultured bovine and human endothelial cells by disrupting the glutathione redox cycle at several points. Endothelial glutathione reductase was selectively inhibited with 1 ,3-bis (chloroethyl)-l-nitrosourea (BCNU). Cellular stores of reduced glutathione were depleted by reaction with diethylmaleate (DEM) or 1 -chloro-2,4-dinitrobenzene (CDNB) or by inhibition of glutathione synthesis with buthionine sulfoximine (BSO). Whereas several strains of untreated bovine and human endothelial cells were resistant to lysis by enzymatically generated hydrogen peroxide, BCNU-treated cells were readily lysed in a timeand dose-dependent manner. Glucose-glucose oxidasemediated lysis of BCNU-treated bovine endothelial cells was catalase-inhibitable and directly related to BCNU concentration and endogenous glutathione reductase activity. Pretreatment ofbovine endothelial cells with BCNU did not potentiate lysis by distilled water, calcium ionophore, lipopolysaccharide, or hypochlorous acid. Depletion of cellular reduced glutathione by reaction with
Introduction
Cells may detoxify hydrogen peroxide (H202) by catalase or the glutathione peroxidase-glutathione reductase system. In tumor cells, susceptibility to lysis by either neutrophil-or macrophagegenerated H202 varies considerably and, in some, is dependent on the activity of the glutathione redox cycle but not catalase (1) . The glutathione redox cycle is also important in protecting normal cells from oxidant injury (2) (3) (4) .
In the glutathione redox cycle the oxidation of reduced glutathione by H202 is catalyzed by glutathione peroxidase. The oxidized glutathione is then reconverted to reduced glutathione by glutathione reductase. The glutathione redox cycle can be disrupted at several points in vitro (4) (Fig. 1) . Glutathione reductase may be selectively inhibited by 1,3-bis (chloroethyl)-l-nitrosourea (BCNU)' (1, 5, 6) . Cellular stores of reduced glutathione can be depleted by formation of a thioether conjugate with electrophilic agents such as l-chloro-2,4-dinitrobenzene (CDNB) (7, 8) or diethylmaleate (DEM) (9-11) in a reaction catalyzed by endogenous glutathione-s-transferase. After cleavage of the -y-glutamyl and glycinyl moieties of the glutathione and acetylation of the cysteine, the resulting mercapturic acid is excreted. Glutathione biosynthesis may be inhibited by buthionine sulfoximine (BSO), a selective inhibitor of y-glutamylcysteine synthetase (4, 8, 11, 12) .
We have examined the role of the glutathione redox cycle in modulating oxidant injury to endothelial cells in culture by disrupting the glutathione redox cycle at several points. Endothelial cell glutathione reductase was selectively inhibited with BCNU and cellular stores of reduced glutathione were depleted by reaction with CDNB or DEM or by inhibition of glutathione synthesis with BSO.
Methods
Preparation of endothelial cells. Bovine aortic and pulmonary artery and human umbilical vein endothelial cells were obtained as previously described (13, 14) and cultured in Waymouth's medium MB-752/1 (Grand Island Biological Co. [Gibco] , Grand Island, NY) supplemented with 10% newborn calf serum (NBCS) (Gibco). Bovine endothelial cells were used in 6th-15th passage. Because bovine endothelial cell susceptibility to lysis by the toxic agents varied somewhat between strains and passage number within the same strain, individual experiments were always performed with cells of the same strain and passage. Human umbilical vein endothelial cells were used in first or second passage only.
Neutrophil preparation. Purified human peripheral neutrophils were prepared by the standard technique of Ficoll-Hypaque gradient centrifugation, dextran sedimentation, and hypotonic lysis of erythrocytes (15 Nuclear, Boston, MA) as previously described (16) . In some experiments endothelial cells were incubated with BSO during the overnight labeling. After overnight incubation, cells were washed three times with 1% NBCS in phosphate-buffered saline (PBS) (Gibco) and then incubated with either BCNU, DEM, CDNB, or ethanol control in 10% NBCS in Waymouth's medium. Endothelial cells were incubated with BCNU for 10 min, after which they were washed twice with 1% NBCS in PBS. Endothelial cells were incubated with DEM and CDNB for 30-60 min without further washing. Test or control medium was then added to a final volume of 100-200 ,l/well, and the cells were incubated at 37°C in a 95% air and 5% CO2 atmosphere. 50-100 ul of cell-free supernatant medium was removed at intervals for determination of specific 5"Crrelease as follows: (A -B/C -B) X 100%. A represents the mean test 5'Cr-cpm released, B represents the mean spontaneous 5'Cr-cpm released, and C represents the mean maximum 5Cr-cpm released. Maximum 5'Cr-release was determined by incubation in 1% Triton X-100 (New England Nuclear). Spontaneous 5Cr-release was determined in control monolayers incubated in 10% NBCS in Waymouth's medium only and was 10-15% of maximum 5'Cr-release after 6 h of incubation. Statistical significance was determined by comparing mean test and mean control 5Cr-cpm released by two-tailed, unpaired, t-statistic.
For neutrophil experiments 50 ,l of neutrophils in 10% NBCS in Waymouth's medium was added and allowed to adhere to the endothelial monolayer for 10 min before addition of 50 Ml of medium with or without phorbol myristate acetate (PMA).
Enzyme assays. Duplicate 25-cm2 flasks of BCNU-treated or ethanol (0.1%) control endothelial cells (2-3 X 106 cells) were solubilized by incubation with 0.2% Triton X-100 at room temperature for 1 h, frozen at -80°C, and the supernatant medium was assayed for glutathione reductase activity and catalase by Dr. Ernest Beutler ofthe Scripps Clinic and Research Foundation, La Jolla, CA (17) . Recovery of glutathione reductase activity after a 1-h incubation in 0.2% Triton X-100 at room temperature and subsequent storage at -80°C for several weeks was 100%. Reduced soluble sulfhydryl content was measured in DEM-, CDNB-, BSO-treated, and control endothelial cells as follows (8, 18, 707 Endothelial Cell Antioxidant Defense Mechanisms min, the cell pellets were resuspended in 1.4 ml of 0.2% Triton X-100 and 2.5% sulfosalicylic acid in EDTA/PBS buffer. Solutions were cleared by centrifugation at 11,000 g for 5 min. A 1.0-ml aliquot of the acidsoluble supernatant medium was then added to 2.0 ml of 0.3 M Na2 HPO4 buffer. Spectrophotometric determinations were performed with a Gilford 300-N spectrophotometer (Gilford Instruments Laboratories, Inc., Oberlin, OH) at 412 nm immediately after the addition of 0.25 ml of 5,5-dithiobis-2-nitrobenzoic acid (40 mg/dl in 1% sodium citrate) (20) . With each assay a standard curve was generated with known amounts of reduced glutathione (5-100 nmol). Recovery of reduced glutathione added at the time ofcell lysis was >90%. Results are expressed as nanomoles of soluble reduced sulfhydryls/106 endothelial cells.
Reagents. Catalase (1 1,800 U/mg protein), bovine serum albumin, reduced glutathione, glutathione reductase, 5,5-dithiobis-2-nitrobenzoic acid, superoxide dismutase (2,700 U/mg protein), glucose oxidase VII, xanthine oxidase gr. I, 5-sulfosalicylic acid, xanthine, hydrogen peroxide (30%), Escherichia coli 055:B5 lipopolysaccharide (LPS), and PMA were obtained from Sigma Chemical Co., St. Louis, MO. Trypan blue dye was obtained from Gibco. Sodium hypochlorite solution was obtained from Scientific Products, Redmond, WA and was standardized by reaction with KI and spectrophotometric measurement of I-formed using E353 = 2.64 X 104 M-' cm-' (21) . BCNU was obtained from Bristol Laboratories Div., Bristol-Meyers Co., Syracuse, NY and dissolved in ethanol at a 100-mg/ml stock just before each experiment. CDNB and DEM were obtained from Sigma Chemical Co., and dissolved in ethanol as 10-2-and 1-M stocks just before use. DL-buthionine-SR-sulfoximine was obtained from Chemalog, Div. of Chemical Dynamics Corporation, South Plainfield, NJ and dissolved in medium of 10-2 M. The calcium ionophore, A23187, was obtained from Calbiochem-Behring Corp., La Jolla, CA and dissolved in dimethyl sulfoxide at 5 X 10-2 M.
Results
Effect of BCNU on endothelial cell lysis by enzymatically generated H202. Pretreatment of bovine pulmonary artery endothelial cells with BCNU (100 Aig/ml) increased their susceptibility to lysis by both the H202-generating system, glucose-glucose oxidase, and the superoxide anion-generating system, xanthinexanthine oxidase (Table I A) . Pretreatment with BCNU alone (100 ,g/ml for 10 min) did not significantly increase endothelial cell 5"Cr-release at 6 h compared with ethanol control. Although the susceptibility of untreated bovine pulmonary artery and aortic endothelial cells to glucose-glucose oxidase-mediated lysis varied somewhat between strains and passage number within the same strain, pretreatment with BCNU always potentiated H202-mediated lysis when assessed in a dose-response assay (Fig. 2) . As with bovine endothelial cells, BCNU also significantly increased the susceptibility of human umbilical vein endothelial cells to lysis by enzymatically generated H202 (Fig. 3) , whereas BCNU alone did not significantly increase 5Cr-release. Both glucose-glucose oxidase-and xanthine-xanthine oxidase-me- (6) 0.4±0.1 1.0±0.1 + Catalase boiled (6) 17.3±2.4 54.9±2.7
Glucose (27 mM) and glucose oxidase (10 mU/ml) or xanthine (10-' M) and xanthine oxidase (100 mU/ml) with or without catalase (3,000 U/ml), catalase boiled for 20 min before, or superoxide dismutase (270 U/ml) were added to 5"Cr-labeled bovine pulmonary artery (A) or aortic (B) endothelial cells that were preincubated for 10 min with BCNU (100 gg/ml) or ethanol control (0.1%). 5'Cr-release was determined at 4 h by aspirating and counting 50-js1 aliquots of the cell-free supernatant medium. Values represent the means of (n) replicates± I SE.
diated lysis of BCNU-treated cells were inhibited by catalase but not by superoxide dismutase (Table I A) . Inhibition of endothelial lysis by catalase was due to its enzymatic activity, since boiled catalase was without protective effect (Table I B) . Glucoseglucose oxidase-mediated bovine endothelial 51Cr-release was associated with trypan blue dye uptake, indicating that endothelial cell lysis had occurred; in a 4-h incubation with glucose (27 mM)-glucose oxidase (10 mU/ml), the specific 5"Cr-release from BCNU-treated aortic endothelial cells was 58.2±1.4% and trypan blue dye uptake was 57.4±4.5% (means offour replicates ±1 SE).
Time course ofH202-mediated endothelial lysis. Incubation with glucose-glucose oxidase did not induce significant 5"Crrelease until relatively late (3-4 h), even in BCNU-treated cells (Fig. 4) . Despite the absence of specific 5"Cr-release in the first several hours of exposure to glucose-glucose oxidase, significant specific 5'Cr-release was observed at 6 h in endothelial cells exposed to the H202-generating system for only 1-2 h before addition of catalase (Fig. 5 ).
Glutathione reductase activity in BCNU-treated endothelial cells. Fig. 6 demonstrates that both bovine endothelial glutathione reductase activity and glucose-glucose oxidase-induced lysis were directly correlated with the concentration of BCNU. without significantly increasing "Cr-release (0% specific "Crrelease in CDNB-treated cells at 6 h). Incubation with CDNB significantly increased bovine aortic endothelial cell susceptibility to glucose-glucose oxidase-mediated lysis (Fig. 8) .
The soluble reduced sulfhydryl content of human umbilical vein endothelial cells incubated with DEM (0.5 mM) for 1 h was reduced 60% compared with ethanol control (4.1 and 3.4 nmol/106 cells with DEM compared with 9.0 and 9.6 nmol/ 106 cells in ethanol control). Although DEM (0.5 mM) alone did not produce significant "Cr-release (<5% specific "Cr-release at 6 h), incubation of human umbilical vein endothelial cells with BCNU (100 /Ag/ml). The with varying concentrations BCNU kpg/ml) of BCNU. Specific 51Cr-release (X) was determined after incubation with glucose (27 mM) and glucose oxidase (10 mU/ml) for 4 h. Glutathione reductase activity with DEM increased their susceptibility to glucose-glucose oxidase-mediated lysis (Fig. 9) .
In concentrations up to 10 mM for 48 h, BSO was not toxic to human umbilical vein endothelial cells as assessed by phasecontrast microscopy and trypan blue dye exclusion. 5"Cr uptake during overnight labeling and spontaneous release during a subsequent 6-h incubation were also unaffected by BSO (1 mM). In contrast to tumor cells where incubation with BSO produced >90% reduction in reduced glutathione levels (8, 11) , incubation of human endothelial cells with BSO (1 mM) for 18 h produced only a 61% decrease in the soluble reduced sulfhydryl content (3.8±0.5 nmol/106 cells in BSO-treated cells compared to 10.6±2.9 nmol/106 cells in control cells, means of three replicate flasks ±1 SD). Increasing the concentration of BSO to 10 mM 5"Cr-labeled bovine aortic endothelial cell monolayers were preincubated for 10 min with BCNU (100 ,ug/ml) or ethanol control (0.1%).
Specific 5"Cr-release was determined after a 4-h incubation with distilled water, A23187 (50 MM), LPS (100 ,ug/ml), or glucose (27 mM (Table III) . Depletion of endothelial reduced glutathione by inhibition of glutathione synthesis by BSO also significantly increased endothelial susceptibility to lysis by PMA-activated neutrophils (Fig. 1 1) . Glucose Oxidose (mU/ml) Figure 9 . Effect of DEM on glucose-glucose oxidase-induced human endothelial "Cr-release. (23, 24, 26) .
The sensitivity of endothelial cell strains to H202-mediated lysis varied. Some human umbilical vein endothelial cell isolates were more readily lysed by glucose-glucose oxidase than others. Bovine endothelial cell strains also varied in their sensitivity to lysis by exogenously generated H202. For example, at the same concentration of glucose oxidase, significant lysis was observed in a strain of bovine aortic cells, whereas a strain of bovine pulmonary artery cells was unaffected (Table I) . Although it is tempting to speculate that susceptibility to oxidant lysis might vary in endothelial cells derived from different vascular sites, it is important to consider that differences in sensitivity to H202-mediated injury in cultured endothelial cells might represent interanimal variation or result from repeated passage. These questions can be resolved only by comparing endothelial cells derived from different vascular sites in the same animal at similar passage.
The time course of H202-mediated endothelial lysis indicates that 5Cr-release is a relatively late event (5-6 h) in control cells and that lysis occurs earlier (3-4 h) when the glutathione redox cycle is disrupted by BCNU. Despite the fact that significant cell lysis was not observed after 2 h of incubation with glucoseglucose oxidase even in BCNU-treated cells, significant 5'Crrelease was still noted at 6 h in cells exposed -to the H202-generating system for only 2 h before the addition of catalase. This suggests that a lethal event may occur relatively early during exposure to enzymatically generated H202, but that it requires several hours to become manifest as 5'Cr-release.
It seems unlikely that BCNU potentiation of H202-mediated endothelial cell lysis represents a nonspecific effect rather than selective inhibition of the glutathione redox cycle. BCNU pretreatment did not increase bovine endothelial cell susceptibility to lysis by nonoxidant toxic agents including distilled water, calcium ionophore, or LPS. Moreover, BCNU pretreatment did not potentiate lysis by reagent hypochlorous acid, a potent oxidizing agent generated by the myeloperoxidase system in neutrophils (27) , whereas lysis by reagent H202 was markedly enhanced in the same cells.
Further evidence that the glutathione redox cycle is specifically involved in protecting cultured endothelial cells against H202-mediated lysis is provided by the observation that depletion of cellular stores of reduced glutathione by reaction with the electrophilic reagents DEM and CDNB and by inhibition of glutathione synthesis with BSO also increased endothelial cell susceptibility to lysis by extracellularly generated H202.
Even prolonged exposure to PMA-activated neutrophils did not produce significant lysis of control bovine and human endothelial cell monolayers at 6 h. Resistance to lysis by PMAactivated neutrophils in our assay appeared to be due, at least in part, to detoxification of H202 by the glutathione redox cycle, since significant catalase-inhibitable 5'Cr-release was observed when BSO-or BCNU-treated endothelial cells were exposed to PMA-activated neutrophils. Since H202 production by neutrophils occurs primarily during an initial burst, the 5'Cr-release observed at 6 h in BCNU-or BSO-treated cells following incubation with PMA-activated neutrophils may be analogous to the 5'Cr-release noted at 6 h after addition of catalase to the glucose-glucose oxidase system at 1.5-2 h.
These studies demonstrate that interruption of one of the major endogenous antioxidant mechanisms, the glutathione redox cycle, significantly increases endothelial cell susceptibility to lysis by H202 in vitro. The fact that disruption of the glutathione redox cycle potentiated H202-mediated lysis in primary passage human umbilical vein endothelial cells as well as the multiply passaged bovine aortic and pulmonary artery endothelial cells suggests that the glutathione redox cycle is a common mechanism for detoxifying H202 in cultured endothelial cells. Further studies are required to determine the relative importance of endogenous catalase and whether simultaneous inhibition of catalase and the glutathione redox cycle would further increase endothelial susceptibility to lysis by enzymatically or neutrophilgenerated H202.
Differences in levels of endogenous antioxidant enzymes in cultured endothelial cells may account for some of the discrepancies in experimental results observed in oxidant injury models in vitro (16, (23) (24) (25) (26) . More importantly, since the endothelium may frequently be exposed to oxygen products generated by inflammatory cells, toxic agents, or hyperoxia, endogenous antioxidant mechanisms such as the glutathione redox cycle may be critical in preventing or limiting vascular injury in vivo. (28) 
